These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 16297773

  • 1. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.
    Kobashigawa JA, Moriguchi JD, Laks H, Wener L, Hage A, Hamilton MA, Cogert G, Marquez A, Vassilakis ME, Patel J, Yeatman L.
    J Heart Lung Transplant; 2005 Nov; 24(11):1736-40. PubMed ID: 16297773
    [Abstract] [Full Text] [Related]

  • 2. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
    Stojanovic I, Vrtovec B, Radovancevic B, Radovancevic R, Yazdanbakhsh AP, Thomas CD, Frazier OH.
    J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation.
    Mahle WT, Vincent RN, Berg AM, Kanter KR.
    J Heart Lung Transplant; 2005 Jan; 24(1):63-6. PubMed ID: 15653381
    [Abstract] [Full Text] [Related]

  • 6. Metaanalysis of statins and survival in de novo cardiac transplantation.
    Mehra MR, Raval NY.
    Transplant Proc; 2004 Jun; 36(5):1539-41. PubMed ID: 15251380
    [Abstract] [Full Text] [Related]

  • 7. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR, Koch DM, Fisher SG, Heroux AL, Kao WG, Johnson MR.
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [Abstract] [Full Text] [Related]

  • 8. Low HDL-C predicts the onset of transplant vasculopathy in pediatric cardiac recipients on pravastatin therapy.
    Hedman M, Pahlman R, Sundvall J, Ehnholm C, Syvänne M, Jokinen E, Jauhiainen M, Holmberg C, Antikainen M.
    Pediatr Transplant; 2007 Aug; 11(5):481-90. PubMed ID: 17631015
    [Abstract] [Full Text] [Related]

  • 9. The University of California at Los Angeles heart transplantation experience.
    Kobashigawa JA, Laks H, Wu G, Patel J, Moriguchi J, Hamilton M, Fonarow G, Fishbein M, Ardehali A.
    Clin Transpl; 2005 Aug; ():173-85. PubMed ID: 17424734
    [Abstract] [Full Text] [Related]

  • 10. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
    Vassalli G, Kaski JC, Tousoulis D, Kiowski W, Turina M, Follath F, Gallino A.
    J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
    [Abstract] [Full Text] [Related]

  • 11. Effect of pravastatin on outcomes after cardiac transplantation.
    Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, Chia D, Terasaki PI, Sabad A, Cogert GA.
    N Engl J Med; 1995 Sep 07; 333(10):621-7. PubMed ID: 7637722
    [Abstract] [Full Text] [Related]

  • 12. Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin.
    Seipelt IM, Crawford SE, Rodgers S, Backer C, Mavroudis C, Seipelt RG, Pahl E.
    J Heart Lung Transplant; 2004 Mar 07; 23(3):317-22. PubMed ID: 15019641
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of statin therapy in patients switched from cyclosporine a to sirolimus after cardiac transplantation.
    Aliabadi AZ, Mahr S, Dunkler D, Grömmer M, Zimpfer D, Wolner E, Grimm M, Zuckermann AO.
    Transplantation; 2008 Dec 27; 86(12):1771-6. PubMed ID: 19104420
    [Abstract] [Full Text] [Related]

  • 16. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 27; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 17. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.
    Martínez-Dolz L, Almenar L, Reganon E, Vila V, Chamorro C, Andrés L, Martínez-Sales V, Moro J, Agüero J, Sánchez-Lázaro I, Salvador A.
    J Heart Lung Transplant; 2008 Jul 27; 27(7):760-6. PubMed ID: 18582806
    [Abstract] [Full Text] [Related]

  • 18. Impact of simvastatin therapy after heart transplantation an 11-year prospective evaluation.
    Wenke K, Meiser B, Thiery J, Reichart B.
    Herz; 2005 Aug 27; 30(5):431-2. PubMed ID: 16132246
    [Abstract] [Full Text] [Related]

  • 19. Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.
    Simes J, Furberg CD, Braunwald E, Davis BR, Ford I, Tonkin A, Shepherd J.
    Eur Heart J; 2002 Feb 27; 23(3):207-15. PubMed ID: 11792135
    [Abstract] [Full Text] [Related]

  • 20. The University of California at Los Angeles experience in heart transplantation.
    Kobashigawa JA, Laks H, Marelli D, Moriguchi JD, Hamilton MA, Fonarow G, Hage A, Kawata N.
    Clin Transpl; 1998 Feb 27; ():303-10. PubMed ID: 10503108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.